The VITAS and Chemed (NYSE: CHE) updated guidance includes the increase and rebasing of hospice reimbursement rates announced by CMS ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE